
Hello ,
We want to congratulate the company NeoStem for having what appears to be an independent group validate importance of their VSEL cells in the body's response to heart failure. In a recent paper a Polish group demonstrated that post-infarct there is an almost three-fold increase in VSEL stem cells entering circulation...this could provide a nice rationale for post-AMI therapy using these cells. Can these cells be mobilized by G-CSF? Would be neat to look !!
A nice set of claims were issued in patent 7,470,538 last week. This covered the use of cord blood derived cells for treatment of cardiac ischemia. We thought that in general hematologists do not advocate using cord blood for other things than post transplant reconstitution...I guess that doesn't stop people from filing IP on them.
Patent 7,470,537 was issued covering a cellular phenotype on fat stem cells. Interestingly on the USPTO site it did not have anyone mentioned as assignee.
An interesting patent, 7,470,425, covered a composition of dissociated cells that have been combined with a "support material" and the used for regenerative purposes. It appears like the inventors came up with a really neat way of circumventing prior art that existed on stem cells and matrices by developing a new, non-obvious, and useful combination of the two.
Happy New Year !!!!!!!!!!!
The successful use of adult stem cells for treatment of cardiac conditions such as heart failure and post infarct recovery has been documented in animal studies and clinical trials. The current patent covers the use of one type of adult stem cell, cord blood stem cells for...
Cell-based therapies for ischemia
Katowice, Poland - Biological significance is a very important factor to look at when evaluating various stem cell technologies or types of stem cells. While companies usually like to believe that their stem cells are "the best", it is often important to ask the question whether the stem cells play a natural role in... Ask a question OR leave your comments.
Neostem's VSEL Cells Have Biological Significance
The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)
LATEST NEWS
Leptin Blocks T Regulatory Cell Expansion
August 23rd, 2009
Mechanism of Multiple Sclerosis Stem Cell Therapy
July 24th, 2009
:
2 Comments
Lithium for Treatment of Multiple Sclerosis
July 15th, 2009
Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells
July 9th, 2009
:
2 Comments
Apoptotic Cells Secrete Angiogenic Factors
June 27th, 2009
Read more news on StemCellPatents.com
LATEST JOBS POSTS
View the StemCellPatents.com Job Board
Thanks again for your help in supporting StemCellPatents.com.